Thermo Fisher Scientific bolsters its gene therapy capabilities by acquiring Brammer Bio for $1.7bn, as the market becomes an âincreasing focusâ for customers.
Original Article: Thermo Fisher acquires gene therapy CDMO Brammer Bio